Cascadia Interbody System
Device Spine
PDI 10888857218765
General payments
$5,820,674
Research payments
$129,892
Through program year 2025, $5,820,674 in general payments and $129,892 in research payments were reported against Cascadia Interbody System (Spine).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $358,919 | 277 |
| 2024 | General | $1,209,980 | 931 |
| 2024 | Research | $75,706 | 27 |
| 2023 | General | $1,183,570 | 950 |
| 2023 | Research | $19,410 | 32 |
| 2022 | General | $1,592,982 | 923 |
| 2022 | Research | $19,727 | 8 |
| 2021 | General | $1,475,223 | 1,445 |
| 2021 | Research | $15,050 | 6 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 27 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
4,526 general · 73 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.